Vasoactive agents in cardiogenic shock (S4 Ep. 33)

Cardiogenic shock occurs in children for a variety of reasons, and there are a variety of vasoactive drugs available to treat the critical condition.  But first we need to understand the pathophysiology and pharmacology to best select the drug for the job, which is no easy task. References Bolick, B.N., Reuter-Rice, K., Madden, M.A., Severin, P.N. (2020). Pediatric Acute Care: A guide for Interprofessional Practice (2nd ed.). Jones & Barlett Learning. Burlington, MA. CDC. (2020). Data and statistics on congenital heart defects. Retrieved online from https://www.cdc.gov/ncbddd/heartdefects/data.html Hughes, H.K., & Kahl, L.K. (2021). Harriet Lane Handbook. Manual for Pediatric House Officers (22nd ed.). Philadelphia, PA: Mosby. Manaker, S., Parsons, P.E., & Finlay, G. (2020). Use of vasopressors and inotropes. Retrieved online from https://www.uptodate.com/contents/use-of-vasopressors-and-inotropes?csi=40383b7b-fb7e-48d4-a09d-2d8706878bb1&source=contentShare Pringle, C.L. (2017). PICU Essentials (1.4.0.305) [Mobile application software]. Retrieved from https://apps.apple.com/us/app/picu-essentials/id1207366521.